Achieve Life Sciences, Inc. (ACHV) Q2 2023 Earnings Call Transcript

Achieve Life Sciences, Inc. (NASDAQ:ACHV) Q2 2023 Earnings Conference Call August 15, 2023 8:30 AM ET

Company Participants

Nicole Jones – Investor Relations

John Bencich – Chief Executive Officer

Jerry Wan – Principal Accounting Officer

Conference Call Participants

Thomas Flaten – Lake Street Capital

Francois Brisebois – Oppenheimer

Farhana Sakloth – Ladenburg Thalmann

Laura Suriel – Alliance Resource Partners

John Vandermosten – Zacks Research


Greetings. Welcome to the Achieve Life Sciences Second Quarter 2023 Earnings Conference Call and Webcast. At this time all participants’ are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded.

At this time, I would like to hand the call over to Nicole Jones, Investor Relations. Thank you. You may begin.

Nicole Jones

Thank you, operator, and thank you to everyone for joining the call today. Today from Achieve, we have John Bencich, Chief Executive Officer; Dr. Cindy Jacobs, President and Chief Medical Officer; and Jerry Wan, Principal Accounting Officer. Achieve’s management will be available for Q&A after the prepared remarks.

I’d like to remind everyone that today’s conference call contains forward-looking statements based on current expectations. These statements are only predictions, and actual results may vary materially from those projected. Please refer to Achieve documents available on our website and filed with the SEC concerning factors that could affect the company.

I’ll now turn the call over to John.

John Bencich

Thank you, Nicole and to everyone who has joined us this morning. The first-half of 2023 has seen the culmination of our ambitions to bring the first smoking cessation products to market in nearly 20-years take a meaningful step forward. Several milestones were met in close proximity, all of which contributed substantial value to the cytisinicline program and to shareholders.

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *